ENTRY       D09668                      Drug
NAME        Sifalimumab (USAN/INN)
FORMULA     C6396H9918N1714O2006S42
EXACT_MASS  144177.5032
MOL_WEIGHT  144266.1963
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKASGYTFT SYSISWVRQA PGQGLEWMGW ISVYNGNTNY
            AQKFQGRVTM TTDTSTSTAY LELRSLRSDD TAVYYCARDP IAAGYWGQGT LVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPSVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS STYLAWYQQK PGQAPRLLIY GASSRATGIP
            DRFSGSGSGT DFTLTISRLE PEDFAVYYCQ QYGSSPRTFG QGTKVEIKRT VAAPSVFIFP
            PSDEQLKSGT ASVVCLLNNF YPREAKVQWK VDNALQSGNS QESVTEQDSK DSTYSLSSTL
            TLSKADYEKH KVYACEVTHQ GLSSPVTKSF NRGEC
            (Disulfide bridge: H22-H96, H143-H199, H260-H320, H366-H424, H225-H'225, H228-H'228, L23-L89, L135-L195, H219-L215)
  TYPE      Peptide
EFFICACY    Immunosuppressant, Anti-IFN-alpha antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of SLE, dermatomyositis, and polymyositis
TARGET      IFNA [HSA:3439 3440 3441 3442 3443 3444 3445 3446 3447 3448 3449 3451 3452] [KO:K05414]
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Interferons
                IFNA
                 D09668  Sifalimumab (USAN/INN)
DBLINKS     CAS: 1006877-41-3
            PubChem: 124490408
///
